Outlook and opportunities for engineered environments of breast cancer dormancy.
Sci Adv
; 10(10): eadl0165, 2024 Mar 08.
Article
em En
| MEDLINE
| ID: mdl-38457510
ABSTRACT
Dormant, disseminated breast cancer cells resist treatment and may relapse into malignant metastases after decades of quiescence. Identifying how and why these dormant breast cancer cells are triggered into outgrowth is a key unsolved step in treating latent, metastatic breast cancer. However, our understanding of breast cancer dormancy in vivo is limited by technical challenges and ethical concerns with triggering the activation of dormant breast cancer. In vitro models avoid many of these challenges by simulating breast cancer dormancy and activation in well-controlled, bench-top conditions, creating opportunities for fundamental insights into breast cancer biology that complement what can be achieved through animal and clinical studies. In this review, we address clinical and preclinical approaches to treating breast cancer dormancy, how precisely controlled artificial environments reveal key interactions that regulate breast cancer dormancy, and how future generations of biomaterials could answer further questions about breast cancer dormancy.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Recidiva Local de Neoplasia
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article